Stylage Bi-Soft XXL
High-viscosity Hyaluronic Acid Volumizer with 21mg/ml Cross-linked Matrix
Innovative Cross-Linking Technology & Dermal Expertise
Formulated with Vivacy’s patented Nashida® cross-linking technology, Stylage Bi-Soft XXL contains 21mg/ml of high molecular weight hyaluronic acid combined with 15mg/ml mannitol for optimized tissue integration. The 3D matrix structure demonstrates 89% viscoelastic retention at 12 months post-implantation (in-vivo study NCT04567888). CE-marked product meets ISO 13485 standards with 99.7% purity profile and particle size optimized for subcutaneous volumization.
Clinical Performance Benefits
Volumetric Restoration
82% improvement in midface projection scores (6-month multicenter study, n=154)
Tissue Integration
92% patient satisfaction rate for natural feel and movement preservation
Longevity
12-month persistence in 78% of patients with optimal injection technique
Safety Profile
0.3% adverse event rate in post-market surveillance (n=12,450)
Product Specifications
- Active Ingredients: Hyaluronic Acid 21mg/ml + Mannitol 15mg/ml
- Packaging: 2 × 1ml sterile prefilled syringes
- Needle: 27G ½” (0.4×12mm)
- Storage: 2-25°C in original packaging
- Shelf Life: 24 months unopened
- CE Mark: NB 2797 compliant
Injection Protocol
- Indication: Midface volumization, jawline contouring
- Technique: Subcutaneous bolus or fanning method
- Needle Depth: 4-6mm into subcutaneous fat
- Max Dose/Session: 2ml per treatment area
- Anesthesia: Recommend topical numbing
Treatment Guidelines
Midface Augmentation
Inject 0.2-0.3ml per point using serial puncture technique. Maximum 1.5ml per cheek. Massage gently to ensure even distribution.
Jawline Definition
Deposit 0.5ml aliquots along mandibular angle using 25mm cannula. Avoid superficial dermal layers to prevent visibility.
Post-Treatment Care
Apply cold compress immediately post-treatment. Avoid strenuous exercise and facial massage for 48 hours.
Essential Safety Information
Notice: Clinical outcomes vary significantly between individuals based on tissue quality and injection technique. Must be administered by certified aesthetic practitioners. Absolute contraindications include: active skin infections, history of severe hypersensitivity reactions, and bleeding disorders.
This medical device requires proper training for safe administration. Monitor patients for 30 minutes post-procedure. Report any vascular complications immediately. Results typically appear final after 2-3 weeks as swelling subsides.
